Robustness properties of optimal insulin bolus administrations for type 1 diabetes

Harald Kirchsteiger, Luigi Del Re, Eric Renard, Margot Mayrhofer

Publikation: Beitrag in Buch/Bericht/TagungsbandKonferenzbeitragBegutachtung

16 Zitate (Scopus)

Abstract

Type 1 diabetic patients compensate the lack of endogenous insulin by basal delivery and bolus injections at meal-times. Exact dosage of the bolus amount is critical to keep the blood glucose both below the maximum limits and above the hypoglycaemia critical values. Determination of the optimal dosage would require information which in general is not available to the patient, who uses empirical rules of thumb to choose the dosage. Although closed loop control obtained by linking insulin delivery from insulin pumps and continuous glucose monitoring systems may be considered as the ultimate solution, multiple daily insulin injections and finger stick glucose measurements remain the current mode of therapy. This paper is concerned with this conventional insulin treatment and is based on the use of model predictive techniques extended to approximate continuous control output signal by single control moves in time. The paper shows that substituting continuous measurement and insulin delivery with discrete values leads to a suboptimal control performance, but that this residual defect is not essential if compared with estimation errors of model parameters, patient inputs and/or measurements. Furthermore, the approach proposed shows in simulation sufficient robustness margins. Computations are done with an extended Bergman model tuned on available data of Type 1 diabetic patients.

OriginalspracheEnglisch
Titel2009 American Control Conference, ACC 2009
Seiten2284-2289
Seitenumfang6
DOIs
PublikationsstatusVeröffentlicht - 2009
Extern publiziertJa
Veranstaltung2009 American Control Conference, ACC 2009 - St. Louis, MO, USA/Vereinigte Staaten
Dauer: 10 Juni 200912 Juni 2009

Publikationsreihe

NameProceedings of the American Control Conference
ISSN (Print)0743-1619

Konferenz

Konferenz2009 American Control Conference, ACC 2009
Land/GebietUSA/Vereinigte Staaten
OrtSt. Louis, MO
Zeitraum10.06.200912.06.2009

Fingerprint

Untersuchen Sie die Forschungsthemen von „Robustness properties of optimal insulin bolus administrations for type 1 diabetes“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren